For nearly two decades, a pair of Israeli chemists pursued the inner architecture of one of humanity's oldest killers, driven by personal memory and scientific curiosity in equal measure. At the Weizmann Institute of Science, Leslie Leiserowitz and Michael Elbaum led an international team of 17 researchers to produce the first complete atomic map of hemozoin — the dark crystals a malaria parasite builds to neutralize its own toxic waste and survive inside human blood. The discovery matters because most antimalarial drugs work by disrupting this very crystallization process, and understanding i
Israeli researchers decode malaria parasite's crystal structure, paving way for new drugs
Cobertura Relacionada
La presidenta encargada Delcy Rodríguez afirmó que Venezuela ha recuperado relaciones con instituciones financieras inte…
FXEmpire · Aug 25 Sanciones a Irán impulsan pronóstico alcista para WTI y Brent hacia $105 y $120Los precios del petróleo se mantienen estables respaldados por sanciones estadounidenses a Irán y riesgos en el transpor…
Google News · Aug 25 El fantasma de la guerra civil se cierne sobre Yemen en plena crisis del GolfoYemen enfrenta una intensificación de enfrentamientos entre los hutíes y las fuerzas armadas yemeníes, marcando los comb…
EL PAÍS · Aug 25 Yemen vive su mayor escalada militar desde 2022 entre hutíes y Arabia SaudíYemen experimenta la peor escalada militar en años con enfrentamientos entre hutíes respaldados por Irán y Arabia Saudí,…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
Israeli researchers' malaria parasite breakthrough has minimal geopolitical impact; primarily a scientific advancement with global health benefits rather than strategic implications.
Strengthens Israel's soft power through scientific leadership in medical research; enhances international scientific collaboration; positions Weizmann Institute as key player in global health innovation without altering state-level power balances.
Similar to Jonas Salk's polio vaccine (1950s)—scientific breakthroughs transcend geopolitics and generate international goodwill, though this malaria research is more incremental than paradigm-shifting.
Lente Econômica
Israeli researchers decoded malaria parasite crystal structure, enabling development of more effective antimalarial drugs against drug-resistant strains with significant implications for pharmaceutical R&D and global health markets.
Consumers in malaria-endemic regions (primarily Africa, Asia, Latin America) could benefit from more effective, potentially cheaper antimalarial treatments with fewer side effects. Reduced disease burden could lower healthcare costs and improve productivity in affected populations.
Potential acceleration of drug approval pathways for antimalarial compounds; increased public health funding for malaria research and treatment programs; possible patent and intellectual property considerations; WHO may update treatment guidelines; increased investment in tropical disease research infrastructure.